logo

For the Inventor, By the Inventor

Moriyama, Japan

Takayuki Ozaki

This inventor holds 8 USPTO granted patents. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1977-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takayuki Ozaki. Retrieved from https://idiyas.com/inventor/takayuki-ozaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Kyoto, JA (1977 - 1978)
  • Kyoto, JP (1979 - 1980)
  • Moriyama, JP (1988 - 1989)
  • Shiga, JP (1999)

Company Filing History:

goldMedal8 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents

Years Active: 1977-1999

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5962453 - Triazine derivative and medicine (1999-10-05),
2. 4859767 - Glucosylmoranoline derivatives and use thereof for inhibiting increase (1989-08-22),
3. 4831055 - Benzoic acid derivatives (1989-05-16),
4. 4755523 - Abietamide derivatives (1988-07-05),
5. 4237132 - Morpholinone derivatives and method of use (1980-12-02),
6. 4162331 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1979-07-24),
7. 4094991 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1978-06-13),
8. 4064252 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1977-12-20),

Title: Takayuki Ozaki: Innovator in Pharmaceutical Chemistry

Introduction

Takayuki Ozaki is a prominent inventor based in Moriyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 8 patents to his name, Ozaki's work has the potential to impact the treatment of various health conditions.

Latest Patents

Among his latest patents, Ozaki has developed a triazine derivative and a medicine that includes glucosylmoranoline derivatives. These compounds are designed to inhibit the increase of hyperglycemic symptoms, showcasing his commitment to addressing critical health issues. The compounds of formula I are particularly noteworthy, as they are useful in the prophylaxis or treatment of hyperglycemic symptoms, where R is an alkyl substituted by one or more hydroxy groups.

Career Highlights

Ozaki is currently associated with Nippon Shinyaku Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovation.

Collaborations

Throughout his career, Takayuki Ozaki has worked alongside notable colleagues such as Shoichi Chokai and Hiromu Murai. These collaborations have fostered a dynamic environment for research and development, leading to groundbreaking advancements in their respective areas of expertise.

Conclusion

In summary, Takayuki Ozaki is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments and innovations. His dedication to research and collaboration exemplifies the spirit of innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…